AbbVie is paying $650 million for a dual-targeting immunotherapy from China’s RemeGen. Elsewhere, Alnylam missed an earnings ...
Dallas Fed Manufacturing Index Drops To -35.8, Missing Analyst EstimatesMon, 28 Apr 2025 15:30:47 GMT Michigan Consumer Sentiment Drops To 52.2, Beating Analyst ExpectationsFri, 25 Apr 2025 16:37:21 ...
Venture capital firm Vertex Ventures, backed by Singapore state investor Temasek, is set to raise nearly $500 million for a new fund that will invest in efforts to step up China's domestic tech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback